IB19-02c

Main Content

HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide

Study #: IB19-02c

Study Status: Published

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.

Citation

Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MM, Modi D, Grunwald MR, Nishihori T, Kuxhausen M, Fingerson S, McKallor C, Bashey A, Kasamon YL, Bolon Y-T, Saad A, McGuirk J, Paczesny S, Gadalla SM, Marsh SGE, Shaw BE, Spellman SR, Lee SJ, Petersdorf EW.

Blood. 2022, Mar 10: 139(10): 139(10):1452-1468. doi: 10.1182/blood.2021013443. Epub 2021, Nov 01. PMCID:PMC8914182.

PubMed

PMID: 34724567

Abstract